David Lambeth
Corporate Officer/Principal at Emory University School of Medicine
David Lambeth active positions
Companies | Position | Start | End |
---|---|---|---|
Emory University School of Medicine | Corporate Officer/Principal | 01/01/1980 | - |
Career history of David Lambeth
Former positions of David Lambeth
Companies | Position | Start | End |
---|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Founder | 01/01/2006 | - |
Training of David Lambeth
Duke University | Doctorate Degree |
Statistics
International
United States | 3 |
Switzerland | 2 |
Operational
Founder | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
- Stock Market
- Insiders
- David Lambeth
- Experience